7-AMINO-4-METHYL-COUMARIN-3-CABOXYALKYL DERIVATES AND FLUORESCENT CONJUGATES THEREOF

Abstract: A novel compound having formula (I), or a reactive derivative or functional equivalent thereof, wherein m is an integer from 1 to 4, and R1 and R2 are same or different and selected from hydrogen and 1-4C alkyl; a fluorescent conjugate having formula (III), wherein m R1 and R2 have the meaning given in claim 1, and R4 is a substituent attached to the keto group of formula (III) by a covalent bond. The new compounds and conjugates are useful as fluorescent labelling agents.

Description: 7-amino-4-methyl-couma_.in-3-carboxyalkyl derivates and fluorescent conjugates thereof The present invention relates to new and novel com¬ pounds for.use as fluorescent labelling agents and the inve ion also includes fluorescent conjugates of such new compou S. Use of derivatives of 7-hydroxy coumariii for fluoro- metric assay of biologically active substances, such as enz mes is known. The labelling of such biologically active sub stances usually takes place by covalent coupling of the lab ling agent to the substance involved. The use of 7-hydroxy 0 coumarin derivatives in fluorometric assays is, however, sub ject to serious drawbacks, in view of the fact that the fluo escence is developed only in the alkaline pH-range, usually ab about pH 8. This is due to the fact that in order to develop fluorescence the hydroxyl group at the 7-position must be 5 ionized. Since sensitive biological materials are involved i the assay the need to make the solutions alkaline before rea ing the fluorescence can- constitute a factor that causes loss of sensitivity due to the necessary dilution with the alkaline reagents. 0 Another drawback of using known fluorescent labelling agents, such as fluorescein isothiocyanate (FITC) is that they emit radiation in a wavelength region that makes it di ficult to distinguish from radiation emitted by autofluor- escence of the biological material, such as cells or tissues 5 This autofluorescence of biological materials is often in the same yellow or green region, and the experi entator must make a subjective assessment as to whether he is examining true labelling characteristics or characteristics due to autofluorescence. 0 Yet another drawback of using 7-hydroxy coumarin deri¬ vatives is the fact that covalent coupling of for example 7- . hydroxy coumarin-3-acetic acid to a polypeptide results in blocking of an amino group of the polypeptide with concomi¬ tant change of its acid-base balance. Such change may well 5 cause alteration of the biological characteristics of the protein. The invention has for its purpose to provide new cou¬ marin derivatives, the use of which does not involve the implications of the known techniques as indicated above. Another object of the invention is to provide fluore- scent conjugates containing such new coumarin derivatives. Still another object is to provide fluorescent labelli compounds emitting in a different region than the region of autofluorescence of biological material, such as cells and tissues. In the instant disclosure the coumarin nucleus will be numbered as shown below, the numbering being given to facili tate the understanding of the following disclosure: To attain these and other objects the invention provid for new and novel compounds having the formula (I). In this structural formula it is preferred that m is 1 or 2, and particularly 1 corresponding to the 3-acetic aci derivative. For practical reasons reactive derivatives invol ing the carboxyl function of compounds CD are preferred, such as esters, for example N-hydroxysuccinimidyl esters, th reason being to facilitate covalent coupling to the biologi¬ cally active material of interest. Accordingly, the compounds of the invention preferably have the following formula CID : wherein R, is an N-oxysubstituent, such as an N-oxysuccini- mide substituent. R, may also, of course, be hydroxy. The invention also provides for new fluorescent conjug tes having the formula CHI) : - R 4 CUD In this formula CHI) 4 may be an organic residue, such as a protein residue or a carbohydrate residue. In the above formulas I-111 R, and R-. may be the same different and are selected from hydrogen and lower alkyl. By the expression "lower" is meant groups containing 1 to 4 car bon atoms. Compounds I and II, wherein R 1 and R~ both are different from hydrogen are preferred in that substitution o the nitrogen atom prevents polymerization between identical molecules to form amide bonds. In regard to compounds of the formula CH) R ? may be such as to result in reactive acyl derivatives, such as hali des particularly acyl chloride. In regard to fluorescent conjugates having formula CH R, may be any organic residue of interest, such as a protei residue attached by an amide bond or a carbohydrate residue covalently attached to the keto group. Compounds according to the invention are particularly useful as fluorescent labelling agents emitting in the blue region resulting in obvious advantages considering the draw¬ backs of the prior art as indicated above. The invention will in the following be illustrated by specific but non-limiting examples with reference to the appended drawings wherein Fig. 1 illustrates the synthesis of 7-amino-4-methyl- coumarin-3-acetic acid; Fig. 2 illustrates the preparation of N-hydroxysuccin-r imide ester of 7-amino-4-methylcoumarin-3-acetic acid; Fig. 3 illustrates absorbance spectra of a compound of this invention, of conjugated casein and of conjugate; Fig. 4 is a diagram showing fluorescence as a function of pH; Fig. 5 shows a standard curve for fluorescence versus concentration; Fig. 6 shows fluorescence as a function of time in enzymatic hydrolysis of a conjugate; and Fig. 7 shows a standard curve for digestion of a conju gate; fluorescence as a function of enzyme concentration. EXAMPLE 1 - The synthesis of 7-amino-4-methylcoumarin-3-acetic acid Preparation of carbethoxyaminophenol To 54.5 g (0.5 mol) of m-aminophenol (Aldrich Chemical Co., U.K.) dissolved in 375 ml of hot ethylacetate, 30 ml of ethylchloroformate Cethylchlorocarbonate 0.3 mol, BDH Chemic U.K.) were added over a 30 minutes period while refluxing. After an additional 10 minutes, the mixture was cooled, the suspension was filtered-, and the filter cake was washed with ethyl acetate. The filtrate was allowed to stand .for 24 hour at room temperature before the solvent was removed in vacuo. The solid was washed with petroleum ether and dried in vacuo Preparation of 7-carbethoxyamido-4-methylcoumarin-3-ethyl acetat The following mixture was then stirred for 3 hours at 25°C: 108 ml of 753 sulphuric acid, 32.4 g CO.15 mol) of di- ethylacetyl succinate CAldrich Chemical Co., U.K.) and 27.2 CO.15 mol) of 3-carbethoxyaminophenol. After addition of 670 ml of ice-water, the suspension was filtered and the filter cake was thoroughly washed with cold water until the washing were neutral. The cake was washed finally with cold absolute alcohol and dried in vacuo. Preparation of 7-carbethoxyamido-4-methylcoumarin-3-acetic acid 20 g of ethyl ester above, was refluxed for 2 hours wit 150 mis of 103 methanolic potassium hydroxide (w/v) . The al- cohol was removed by rotatory evaporation. A precipitate was formed by addition of 2 M HCl, which was filtered off, washe with cold distilled water until the washing was free of acid and dried in vacuo. The hydrolysis of the above ester with methanolic pota sium hydroxide was followed by thin layer chromatography (Merck aluminium sheets, Silica gel 60, Art 5553, BDH Chemi¬ cals, U.K.) using ethylacetate:methanol (90:10) as a develop ing solvent and was viewed under u.v. illumination at 350 nm The unhydrolyzed ethylester above can be easily distinguishe from coumarin acetic acid after hydrolysis, which moves with the solvent, while the latter remains at the origin. Preparation of 7-amino-4-methylcoumarin-3-acetic acid The carbethoxy group was removed as follows: 9.2 ml of glacial acetic acid, 8.2 ml concentrated sulphuric acid and 8.0 g of 7-carbethoxyamido-4-methylcoumarin-3-acetic acid were refluxed for 3 hours. After being cooled to 25°C, the mixture was poured into 120 ml of an ice-water mixture, then warmed to 70°C and treated with Norit A-Celite (1:1) (BDH Chemicals, U.K.). After being filtered, warmed and washed with 180 ml of hot water, the filtrate was left to cool at room temperature to crystallize. The 7-amino-4-methylcoumari -3-acetic acid crystals were filtered, washed with cold dis¬ tilled water and then with cold ethanol. The crystals were left to dry in vacuo. The synthesis of 7-amino-4-methylcouma rin-3-acetic acid is summarized in Fig. 1. Spectroscopic data and elemental analysis of 7-amino-4-methy coumarin-3-acetic acid Nuclear magnetic resonance spectroscopy The 90 MHz H N.M.R. (DMSO-dg) was in good agreement with the proposed structure of 7-amino-4-methylcoumarin-3- -acetic acid, in which a singlet at δ 2.25 integrated for three protons was assigned to the methyl group at C-4, also another singlet was located at <5 3.48 for two protons and it chemical shift was typical for a methylene group at C-2. The primary amino protons appeared as a broad peak at 6 6.04, also the aromatic protons appeared at the typical chemical shift for the aryl ring protons, where H-5 appeared as a dou let at δ 7.46, H-6 as a double-doublet at δ 6.6 and H-8 as a singlet at δ 6.45. Infra-red spectroscopy Further characterization of the 7-amino-4-methylcoumar -3-acetic acid was carried out by IR spectroscopy using an SP200 I.R. spectrometer. The IR spectrum showed the expected absorption of the primary NH- stretching bond at v 3450 and v 3360 wave numbers (cm -1) , and the C=0 absorption appeared at v 1685 wave number (cm ). Elemental analysis The melting point of 7-amino-4-methylcoumarin-3-acetic acid was above 305°C. Elemental analysis: Found C 60.07%; H 4.675%; N 5.675..; 0 29. " 58%; C- j ^H^O^, Required: C 61.803; H 4.7213; N 6.003; 0 27.4793. EXAMPLE 2 Preparation of 7-amino-4-methylcoumarin-3-acetyl chloride The reaction was carried out in a 500 ml two-necked re action flask, containing 50 ml toluene, 7-amino-4-methylcoum rin-3-acetic acid (prepared as per Example 1 above), 699 mg (3 mmol) and thionyl chloride, 0.278 ml (446 ng, 3.75 mmol, BDH Chemicals, U.K.). Nitrogen was passed through the mixtur during the reaction. The mixture was refluxed for 2 hours on an oil bath (temperature 130 - 150 C) . The solvent was remo ed by rotatory evaporation and the precipitate was dried in vacuo. Labelling of proteins using acyl chloride A solution of the protein (1 g in 20 ml) is adjusted t pH 10 with NaOH and cooled in an ice bath. The 7-amino-meth coumarin-3-acetyl chloride (125 mg) is added in three portio with stirring over a 20 minutes period. The reaction mixture was kept at 4°C for a further 3 hours, then centrifuged and and dialysed overnight against 10 mM phosphate buffered sali pH 7.4 to remove excess reactants . A final purification by gel filtration can be carried out if necessay followed by freeze drying. The ester linked fluorescence (presumed to be tyrosine or serine residues) is relatively unstable at alkal ne pH's and slowly hydrolyses on storage in solution. EXAMPLE 3 Preparation of N-hydroxysuccinimide ester of 7-amino-4- -methyl-coumarin-3-acetic acid 7-amino-4-methylcournarin-3-acetic acid, 466 mg (2 mmol) was dissolved in 10 ml of dimethylformamide (DMF) . To the mi ture was added 90 ml of tetrahydrofuran (THF) and 276 mg (2.4 mmol) of N-hydroxysuccinimide with cooling. To this 494 mg (2.4 mmol) of N,N'-dicyclohexylcarbodi-i ide was adde The mixture was stirred overnight in the cold, and the dicyc hexylurea formed was then filtered off and the tetrahydrofur was removed by rotatory evaporation. The N-hydroxysuccinimid ester was left to crystallize in dimethylformamide overnight in the cold. The crystals were washed with diethylether and the active ester so obtained was used without further purifi cation. The preparation of the ester is summarized in Fig. 2 EXAMPLE 4 General method of protein labelling Casein labelled using the N-hydroxysuccinimide ester of 7-amino-4-meth lcoumarin-3-acetic acid T g of casein was left to dissolve overnight in 20 ml of 50 mM sodium tetraborate buffer, pH 9.0. After removal of any undissolved particles by centrifugation, 99 mg of the above N-hydroxysuccinimide ester was added in three portions over a 1 hour period with vigorous stirring. The reaction mixture was kept at room temperature for a further 5 hours. The solution was then centrifuged, and the soluble fluoresce casein was precipitated by the addition of 0.5 M sodium formate/HCl buffer, pH 4.0. The precipitate was filtered off and washed, first with the above buffer, and then with 10 mM phosphate-buffered saline (0.15 M NaCl/10 mM sodium phospate buffer), pH 4.0, until the washings were substantially free of fluorescence. Final traces of fluorescent contamination were removed by re-dissolving the labelled casein in 20 ml of 10 mM-phosphate buffered saline, pH 9.0, and dialysed overnight against a large volume of 10 mM phosphate buffered saline, pH 7.2, before freeze-drying the product. The reaction of labelling casein (protein) was followe by thin layer chromatography (Merck Aluminium sheets, silica gel 60, Art 5553, BDH Chemicals, U.K.) using methanol:acetic acid (9.5:5) as a developing solvent and was viewed under u.v illumination at 350 nm. The labelled protein can be easily distinguished from the uncoupled fluorophore, since it remai at the origin, while the free fluorophore moves with the sol vent. Further purification was achieved by redissolving the 7-amino-4-methylcoumarin-casein (1 g) in the minimum of phos phatebuffered saline (10 mM) , pH 7.4, and applied to Sephade G-25 (Pharmacia Fine Chemicals, Jppsala, Sweden), 2 x 45 cm column. The column was eluted with the same buffer, the acti fractions not retained by the column were pooled, ' concentrat and dialysed before freeze-drying the product. As before, the effectiveness of the fluorescent label¬ ling procedure can be monitored by the appearance of a stron absorption band at 350 nm at pH 7.4 with solutions of the co • jugated casein (see Fig. 3). Unconjugated casein has negligi le absorbance under these conditions. Again, assuming that the spectral characteristics of t fluorophore are not affected by conjugation, the. conditions described above produce a degree of substitution of 0.070 μm of 7-amino-4-methylcoumarin-3-acetic acid/mg of protein equi valent to approximately 1.6 basic amino acid residues being labelled on each molecule of casein. EXAMPLE 5 Specific method for labelling lectins Conjugation of Bandeiraea simplicifolia lectin with 7-amino-4-meth lcoumarin-3-acetic acid 50 mg of Bandeiraea simplicifolia lectin was left to dissolve in 10 ml of 50 mM sodium tetraborate buffer, pH 9.0, containing 0.1 mM calcium chloride. 0.5 g of methyl- -alpha-D-galactopyranoside (excess) was added to the above solution to protect binding sites and was left to stir for minutes. To this, 20 mg of N-hydroxy-succinimide ester of 7-amino-4-methylcoumarin-3-acetic acid was added in three portions over a 1 hour period with vigorous stirring. The reac tion mixture was left at room temperature for a further 5 hours. The solution was then centrifuged, and the soluble fluorescent lectin was dialysed against a large volume of 10 mM phosphate buffered saline, pH 7.0 (10 litres), contain ing 0.1 mM calcium chloride, before freeze-drying the produc EXAMPLE 6 Hydrolysis of 7-amino-4-methylcoumarin-casein by proteases The 7-amino-4-methylcoumarin-3-acetic acid fluorophore generates a maximum fluorescence over a wide range of pH, from 3.6 to 10.3 (see Fig. 4), and showed a linearity with different concentrations of 7-amino-4-methylcoumarin-3-aceti acid when the fluorimeter was set to read 1000 arbitrary un with a freshly-prepared 0.5 ym solution of the"above fluoro- phor (cf. Fig. 5). The method of assay involves .incubation the optimum pH for proteinase activity, precipitation of un- hydrolysed casein with trichloroacetic acid, followed by ad¬ justment of a sample with sodium formate to pH 3.8 for fluo- rimetry, using the Locarte LMF fluorimeter. To 80 μl of the appropriate assay buffer, was added 10 μl of enzyme solution. After equilibration at 37°C, 10 μl of a stock substrate solution was added (20 mg of 7-amino-4- -methylcoumarincasein/ml in 10 mM phosphate-buffered saline, pH 7.4) to give a final substrate concentration of 0.2 mg i the assay mixture. After incubation for up to 30 minutes, t reaction was stopped and unhydrolysed substrate was precipi¬ tated by the addition of 0.5 ml of 53 (w/v) trichloroacetic acid. 2 ml of 0.5 M sodium formate, pH 4.0, was added after 5 minutes of precipitation with trichloroacetic acid and was left for another 5 minutes at room temperature before filtr tion for fluorimetry. Controls were performed by adding enzyme subsequent to incubation and trichloroacetic acid precipitation, and a suitable fluorescent standard, 0.5 μM solution of 7-amino-4 -methylcoumarin-3-acetic acid in the above sodium formate buffer, set to read 1000 arbitrary units. When a low concentration os enzyme was used, the libe ration of soluble fluorescent products was linear with time over a considerable period for alpha-chymotrypsin, whereas trypsin at low concentration and on longer incubation, may well result in some denaturation of the enzyme (cf. Fig. 6). Its stability increases in the presence of CaCl and this a rees with the similar results obtained for the trypsin-like enzyme, plas in, which undergoes autolytic alteration in so¬ lution. These initial rates of liberation are proportional t enzyme concentration (See Fig. 7). The sensitivity of the me thod under the above conditions of assay is such that 5 ng o trypsin or alpha-chymotrypsin is sufficient to produce a so¬ luble fluorescence which can be measured after a 30 minutes incubation. Cathepsin B at concentrations as high as 2 μg o pure enzyme/assay mixture had no significant effect after incubations of up to 2 hours. The present technique of using 7-amino-4-methylcoumar -3-acetic acid as a fluorophor to label casein, compared to the 4-methylumbelliferone-3-acetic acid method, is approxim tely 10 times more sensitive, and the possibility of the ph sical adsorbance of the proteases on their macromolecular substrates, which cause a lowering of activity, may be elim nated because the amount of substrate used in each assay fo 7-amino-4-methylcoumarin-casein method is 10 times lower, 0 mg/assay, compared to the 4-methylumbelliferyl-casein metho 2 mg/assay. EXAMPLE 7 Fabry's disease Identification of carrier status by fluorescent lectin bind Fabry's disease is a hereditary disorder of glycosphi lipid metabolism characterized by a deficiency of the lysos enzyme α-galactosidase A and the concomitant accumulation o galactose-terminal glycolipids in most tissues. The major s rage product is cera ide trihexoside (Gal 1-4 GalB1-4Glc. 81-1'-cer). This is an X-chromosome-linked disorder and because of the random nature of X-inactivation the persisting enzyme levels in various organs and tissues of female carriers may be very variable and are not diagnostically reliable. We therefore tested skin fibreblasts from patients and carriers of Fabry's disease along with cells from normal subjects for the specific accumulation of α-galactose-terminal storage products as a diagnostic indicator. Fibroblasts from patient carriers and controls grown on coverslips were fixed with 3.53 paraformaldehyde in 10 mM-PBS, washed in PBS and treate with acetone/ethanol (1:1, v/v) at -20°C for 40 minutes. The fixed cells were then reacted for 20 minutes at room temperature with a solution of the labelled lectin (see Example 5) in phosphate buffer (175 mg/ml) at pH 7.0 in the presence of 0.1 mM-CaC^. Controls to verify the specificity of the sugar binding were carried out in the same way but incorporating 10 mM- -methyl- -galactoside as a competitor during the.binding pro cess. Preparations were viewed by fluorescence microscopy, excitation 340-380 nm with suppression at 430 nm. Cells from Fabry patients demonstrated strong fluores¬ cence that was completely abolished in the presence of methy -α-galactoside, indicating that the lectin was selectively bound to the storage material. Little or no fluorescence cou be observed in control fibroblasts from normal subjects. Significant numbers of cells in the cultures from fe¬ male carriers were also seen to have accumulated storage pro duct on this evidence. Thus the method offers the possibilit of identifying the carrier status of female siblings of Fabr hemizygotes on the basis of identification of a proportion o cells that react positively to the lectin. Lectin labelled with fluorescein isothiocyanata, proved to be an unsuitable reagent for staining the cells because of the native auto- fluorescence of the granules, which was hardly distinguished between the normal and the mutant cells in Fabry's disease. EXAMPLE 8 Labelling anti-mouse antibodies 7-amino-4-methylcoumarin-3-acetic acid was used succes fully to label anti-mouse antibodies to detect monoclonal antibody directed against the glomerular basement membrance of normal human kidney under the ultra-violet microscope.

Claims: CLAIMS A nove l compound having the formul a ( I ) or a reactive derivative or functional equivalent thereof, wherein m is an integer from 1 to 4, and R.. and R-, are same or different and selected from hydrogen and 1-4C alkyl. 2. A compound according to claim 1, wherein m is 1 or 2. 3. A compound according to claim 1 or 2, wherein m is 1. 4. A compound according to any preceding claim having the formula (II) : wherein R, is an N-oxy substituent. 5. A compound according to claim 4, wherein R-, is an N-oxysuccinimide substituent. 6. A compound according to claim 4 or 5, wherein R-.- is selected from hydroxy and halogens, particularly chloro. 7. A compound according to any of claims 1-6 for use as a fluorescent labelling agent. 8. A compound according to claim 7 for use as a fluorescen labelling agent in the blue region. 9. A fluorescent conjugate having the formula (HI): wherein m R 1 and R- have the meaning given in claim 1 , and R, is a substituent attached to the keto group of formula (HI) by a covalent bond. 10. A conjugate according to claim 9, wherein R. is an organic residue. 11. A conjugate according to claim 10, wherein R. . protein residue attached by an amide bond. 12. A conjugate according to claim 10, wherein R. is a carbohydrate residue. 13. A conjugate according to any of claims 7-12, wherein m is one. 14. A conjugate according to any of claims 9-13, wherein R.. and R 2 are both methyl.

Inventors: ROBINSON DON, ROBINSON, DON
Applicants: BIOCARB AB
Application year: 1986
Main classification: C07D311
IPC codes: C07D311, C12Q1, G01N33